Ocular Therapeutix OCUL

$ 8.6 -2.05%

Quarterly report 2024-Q3
added 11-14-2024

Ocular Therapeutix Balance Sheet 2011-2024 | OCUL

Annual Balance Sheet Ocular Therapeutix

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-185 M	-72 M	-136 M	-185 M	4.91 M	-29.3 M	-23.5 M	-17.3 M	58.8 M	-22.5 M	-15 M	-19.8 M	-
Long Term Debt	9.14 M	28.7 M	26.4 M	41.2 M	49.3 M	24.8 M	12.5 M	14.1 M	15.3 M	13.5 M	651 K	2.26 M	-
Long Term Debt Current	1.59 M	1.6 M	1.62 M	1.36 M	1.13 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	70.3 M	28 M	15.9 M	14.6 M	15.3 M	13.6 M	932 K	2.6 M	-
Total Current Liabilities	34.9 M	31.4 M	26.3 M	26.7 M	12 M	9.16 M	13.4 M	8.3 M	5.38 M	5.87 M	-	-	-
Total Liabilities	161 M	114 M	117 M	186 M	82.4 M	37.2 M	29.3 M	22.9 M	20.7 M	19.5 M	4.27 M	6.07 M	-
Deferred Revenue	255 K	576 K	-	-	-	-	-	-	42 K	188 K	250 K	-	-
Retained Earnings	-698 M	-617 M	-546 M	-539 M	-384 M	-297 M	-237 M	-174 M	-129 M	-89.4 M	-60.8 M	-47.5 M	-
Total Assets	252 M	149 M	205 M	262 M	78.7 M	73 M	55.4 M	74.9 M	110 M	78.2 M	19.1 M	25.3 M	-
Cash and Cash Equivalents	196 M	102 M	164 M	228 M	54.4 M	54.1 M	41.5 M	32.9 M	30.8 M	37.4 M	17.5 M	23.9 M	-
Book Value	91.1 M	35.4 M	88 M	76.1 M	-3.63 M	35.9 M	26.1 M	52 M	89.6 M	58.7 M	14.9 M	19.2 M	-
Total Shareholders Equity	91.1 M	35.4 M	88 M	76.1 M	-3.63 M	35.9 M	26.1 M	52 M	89.6 M	58.7 M	-59.5 M	-46.6 M	-

All numbers in USD currency

Quarterly Balance Sheet Ocular Therapeutix

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5.59 M	6.1 M	6.41 M	9.14 M	8.76 M	30 M	29.4 M	28.7 M	28.2 M	27.6 M	27 M	26.4 M	25.9 M	25.3 M	24.8 M	24.3 M	24.3 M	24.3 M	24.3 M	24.3 M	24.3 M	24.3 M	24.3 M	-	-	-	-	-	18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	138 M	139 M	131 M	161 M	155 M	119 M	119 M	114 M	112 M	107 M	108 M	117 M	130 M	150 M	160 M	186 M	186 M	186 M	186 M	82.4 M	82.4 M	82.4 M	82.4 M	37.2 M	37.2 M	37.2 M	37.2 M	29.3 M	29.3 M	29.3 M	29.3 M	22.9 M	22.9 M	22.9 M	22.9 M	20.7 M	20.7 M	20.7 M	20.7 M	19.5 M	19.5 M	19.5 M	19.5 M	4.27 M	4.27 M	4.27 M	-	-	-	-	-	-	-	-	-
Deferred Revenue	190 K	269 K	263 K	255 K	317 K	391 K	463 K	576 K	603 K	1.19 M	1.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	42 K	42 K	42 K	42 K	188 K	188 K	188 K	188 K	250 K	250 K	250 K	-	-	-	-	-	-	-	-	-
Retained Earnings	-843 M	-806 M	-762 M	-698 M	-668 M	-668 M	-647 M	-617 M	-601 M	-577 M	-558 M	-546 M	-542 M	-545 M	-536 M	-539 M	-539 M	-539 M	-539 M	-384 M	-384 M	-384 M	-384 M	-297 M	-297 M	-297 M	-297 M	-237 M	-237 M	-237 M	-237 M	-174 M	-174 M	-174 M	-174 M	-129 M	-129 M	-129 M	-129 M	-89.4 M	-89.4 M	-89.4 M	-89.4 M	-60.8 M	-60.8 M	-60.8 M	-	-	-	-	-	-	-	-	-
Total Assets	490 M	517 M	539 M	252 M	162 M	123 M	129 M	149 M	159 M	173 M	188 M	205 M	218 M	231 M	243 M	262 M	262 M	262 M	262 M	78.7 M	78.7 M	78.7 M	78.7 M	73 M	73 M	73 M	73 M	55.4 M	55.4 M	55.4 M	55.4 M	74.9 M	74.9 M	74.9 M	74.9 M	110 M	110 M	110 M	110 M	78.2 M	78.2 M	78.2 M	78.2 M	19.1 M	19.1 M	19.1 M	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	427 M	460 M	483 M	196 M	111 M	66.6 M	79 M	102 M	121 M	135 M	145 M	164 M	179 M	192 M	209 M	230 M	228 M	228 M	228 M	54.4 M	54.4 M	54.4 M	54.4 M	54.1 M	54.1 M	54.1 M	54.1 M	41.5 M	41.5 M	41.5 M	41.5 M	32.9 M	32.9 M	32.9 M	32.9 M	30.8 M	30.8 M	30.8 M	30.8 M	37.4 M	37.4 M	37.4 M	37.4 M	17.5 M	17.5 M	17.5 M	-	23.9 M	-	-	-	5.33 M	-	-	-
Book Value	352 M	378 M	408 M	91.1 M	7.85 M	3.09 M	9.71 M	35.4 M	46.2 M	65.8 M	79.8 M	88 M	87.3 M	80.2 M	83.4 M	76.1 M	76.1 M	76.1 M	76.1 M	-3.63 M	-3.63 M	-3.63 M	-3.63 M	35.9 M	35.9 M	35.9 M	35.9 M	26.1 M	26.1 M	26.1 M	26.1 M	52 M	52 M	52 M	52 M	89.6 M	89.6 M	89.6 M	89.6 M	58.7 M	58.7 M	58.7 M	58.7 M	14.9 M	14.9 M	14.9 M	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	352 M	378 M	408 M	91.1 M	7.85 M	3.09 M	9.71 M	35.4 M	46.2 M	65.8 M	79.8 M	88 M	87.3 M	80.2 M	83.4 M	76.1 M	76.1 M	76.1 M	76.1 M	-3.63 M	-3.63 M	-3.63 M	-3.63 M	35.9 M	35.9 M	35.9 M	35.9 M	26.1 M	26.1 M	26.1 M	26.1 M	52 M	52 M	52 M	52 M	89.6 M	89.6 M	89.6 M	89.6 M	58.7 M	58.7 M	58.7 M	58.7 M	-59.5 M	-59.5 M	-59.5 M	-	-46.6 M	-	-	-	-32.7 M	-	-	-

All numbers in USD currency